RE
CLMT icon

RBC Europe’s Calumet Specialty Products CLMT Stock Holding History

RBC Europe’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,100
Closed -$8.7K – 724
2021
Q3 		$8.7K Hold
1,100
– – ﹤0.01% 961
2021
Q2 		$7.56K Buy
+1,100
New +$6.79K ﹤0.01% 1002

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WWM
Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RBC Europe's CLMT Position: Q4 2021 in Review

RBC Europe sold out of Calumet Specialty Products (CLMT) in Q4 2021, closing a stake of 1,100 shares — an estimated $8.7K sold.

RBC Europe first reported a position in CLMT in Q2 2021 and held it in 2 quarters. The position peaked at $8.7K in Q3 2021. 70 funds tracked by Wall St. Rank hold CLMT as of Q4 2021.

  • RBC Europe reported no remaining Calumet Specialty Products position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 1,100 Calumet Specialty Products shares in Q4 2021, an estimated $8.7K.
  • RBC Europe first reported a position in Calumet Specialty Products in Q2 2021 and held it in 2 quarters.
  • RBC Europe's Calumet Specialty Products position peaked at $8.7K in Q3 2021.
  • 70 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.